Novartis está ampliando sus perspectivas en enfermedades cardiometabólicas al llegar a un acuerdo para adquirir Anthos Therapeutics, una empresa en pruebas decisivas con un medicamento…
Editor’s Note: This article was originally published on February 13, 2022 and is being reprinted. In this interview, Dr. Malcolm Kendrick, a board-certified family physician…